SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK
- Yutaka Okawa
- , Teru Hideshima
- , Paul Steed
- , Sonia Vallet
- , Steven Hall
- , Ken Huang
- , John Rice
- , Amy Barabasz
- , Brianna Foley
- , Hiroshi Ikeda
- , Noopur Raje
- , Tanyel Kiziltepe
- , Hiroshi Yasui
- , Sotaro Enatsu
- , Kenneth C. Anderson
Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Artikel in Fachzeitschrift
203
Link wird in einem neuen Tab geöffnet
Zitate
(Scopus)